41 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... known to have HIV ... diagnosed with HIV ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Osteomyelitis - IDSA ... #Parenteral #IV ... Osteomyelitis #management #treatment ... #pharmacology #idsa
Treating Condyloma Acuminatum (Genital Warts) - IDSA
Patients with HIV may have larger or more numerous warts,
Genital Warts) - IDSA ... Patients with HIV ... than HIV-negative ... Genital #Warts #idsa ... #hpv
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... for effective treatment ... candida #mucosal #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis) in HIV-AIDS ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Tx Management (IDSA ... Bezlotoxumab 10 mg/kg IV ... /severe CDI IDSA ... 2021 CDI Treatment ... infectiousdiseases #IDSA
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention #Treatment
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... belli Infection in HIV-AIDS ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... #Prevention #Treatment